Related Experiment Video
Updated: Mar 22, 2026

Comprehensive Analysis of Drug Response using the FLICK Assay
Published on: June 6, 2025
Biflorin induces cytotoxicity by DNA interaction in genetically different human melanoma cell lines
Ana Carolina Lima Ralph1, Danielle Queiroz Calcagno2, Luciana Gregório da Silva Souza3
1Pharmaceutical Sciences, Federal University of Amazon, Av. General Rodrigo Octávio, 6200, Coroado, 69077-000 Manaus, Amazonas, Brazil; Faculdade de Ciências Farmacêuticas, Universidade Federal do Amazonas, Rua Alexandre Amorim, 330, Aparecida, CEP: 69010-300, Manaus, Amazonas, Brazil.
Abstract:
Cancer is a public health problem and the second leading cause of death worldwide. The incidence of cutaneous melanoma has been notably increasing, resulting in high aggressiveness and poor survival rates. Taking into account the antitumor activity of biflorin, a substance isolated from Capraria biflora L. roots that is cytotoxic in vitro and in vivo, this study aimed to demonstrate the action of biflorin against three established human melanoma cell lines that recapitulate the molecular landscape of the disease in terms of genetic alterations and mutations, such as the TP53, NRAS and BRAF genes. The results presented here indicate that biflorin reduces the viability of melanoma cell lines by DNA interactions. Biflorin causes single and double DNA strand breaks, consequently inhibiting cell cycle progression, replication and DNA repair and promoting apoptosis. Our data suggest that biflorin could be considered as a future therapeutic option for managing melanoma.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...

